Vaxcyte ($PCVX) Insider Trading & Smart Money Activity

Vaxcyte, Inc. · Biotechnology · Latest filing Oct 5, 2026

Vaxcyte, Inc. ($PCVX) has 17 insider trades, 5 congress trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($6.44M), net -$6.44M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
4
Net insider $ (12 mo)
-$6.44M
Congress trades (12 mo)
5
13F moves on file
2
Analyst ratings on file
0

PCVX insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 3 · $3.10M 4 / 0 1 / 0
Q3 2026 0 0 1 / 0 0 / 0
Q4 2026 0 3 · $3.34M 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PCVX insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Wassil JimEVP, Chief Scientific Ofc, COO Sell (Open-market sale) 10b5-1 18K sh $1.56M -4.3% —
Insider Cowan ElviaSVP, Finance & CAO Sell (Open-market sale) 10b5-1 19K sh $1.65M -4.3% —
Insider Wassil JimEVP, Chief Scientific Ofc, COO Sell (Open-market sale) 10b5-1 2.25K sh $127.51K +16.0% —
Congress Gilbert Ray Cisneros Jr. Purchase $1,001 - $15,000 -0.7%+7.5% —
Insider Grant PickeringCHIEF EXECUTIVE OFFICER Sell (Open-market sale) 10b5-1 24.24K sh $1.34M +0.8%-1.8% —
Insider Moncef Slaoui Buy (Grant or award) 26.06K sh +10.8%+7.5% —
Insider Grant PickeringCHIEF EXECUTIVE OFFICER Sell (Open-market sale) 10b5-1 23.46K sh $1.23M +4.4%+7.9% Read
Insider Grant PickeringCHIEF EXECUTIVE OFFICER Buy (Option exercise) 225 sh $402.75 +4.4%+7.9% Read
Insider Andrew GuggenhimePRESIDENT AND CFO Sell (Open-market sale) 10b5-1 10K sh $530K +4.4%+7.9% Read
Insider Andrew GuggenhimePRESIDENT AND CFO Buy (Option exercise) 10K sh $53.50K +4.4%+7.9% Read
Insider Carlos Paya Buy (Grant or award) 11.39K sh +5.1%+14.5% —
Insider Heath Lukatch Buy (Grant or award) 2.27K sh +5.1%+14.5% —
Insider Teri Loxam Buy (Grant or award) 2.27K sh +5.1%+14.5% —
Insider Jacks Lee Buy (Grant or award) 11.39K sh +5.1%+14.5% —
Insider Halley Gilbert Buy (Grant or award) 2.27K sh +5.1%+14.5% —
Insider John Furey Buy (Grant or award) 11.39K sh +5.1%+14.5% —
Insider Anne Drapeau Buy (Grant or award) 2.27K sh +5.1%+14.5% —
Insider Olivier Brandicourt Buy (Grant or award) 11.03K sh +5.1%+14.5% —
13F Farallon Capital Management Added +1.26M sh $73.30M -9.7%-5.4% —
Congress Gilbert Cisneros Purchase $1,001 - $15,000 -13.1%-12.5% Read
Congress Gilbert Cisneros Purchase $1,001 - $15,000 -13.1%-12.5% Read
Congress Gilbert Cisneros Purchase $1,001 - $15,000 -9.7%-12.5% Read
Congress Gilbert Cisneros Purchase $1,001 - $15,000 -9.7%-12.5% Read
13F Avoro Capital Advisors Sold out -1M sh Read

1W / 1M / 6M = how PCVX moved from the trade or filing date.

Insider trading in PCVX: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Wassil Jim EVP, Chief Scientific Ofc, COO 2 -$1.69M Oct 5, 2026
Cowan Elvia SVP, Finance & CAO 1 -$1.65M Oct 5, 2026
Grant Pickering CHIEF EXECUTIVE OFFICER 3 -$2.57M Jun 26, 2026
Moncef Slaoui 1 — Jun 22, 2026
Andrew Guggenhime PRESIDENT AND CFO 2 -$530K Jun 18, 2026
Carlos Paya 1 — Jun 15, 2026
Heath Lukatch 1 — Jun 15, 2026
Teri Loxam 1 — Jun 15, 2026
Jacks Lee 1 — Jun 15, 2026
Halley Gilbert 1 — Jun 15, 2026
John Furey 1 — Jun 15, 2026
Anne Drapeau 1 — Jun 15, 2026
Olivier Brandicourt 1 — Jun 15, 2026

Members of Congress trading PCVX

Institutions moving PCVX (13F)

Frequently asked questions

Are PCVX insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 6 open-market sales worth $6.44M, a net -$6.44M.

What is the latest insider trade in PCVX?

Wassil Jim, EVP, Chief Scientific Ofc, COO filed a sell (open-market sale) of 18K sh worth $1.56M on Oct 5, 2026.

Which members of Congress traded PCVX?

5 disclosed trades by Gilbert Cisneros and Gilbert Ray Cisneros Jr.. The latest was on Jul 16, 2026.

Which institutions changed their PCVX positions?

Recent 13F filers moving the stock include Farallon Capital Management and Avoro Capital Advisors.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text